Lori L. Huston

Lori L. Huston serves as a key procurement lead at the Naval Health Research Center, supporting the Department of Defense’s mission to enhance the health and operational readiness of Navy and Marine Corps personnel through advanced biomedical research and diagnostic innovation. She manages acquisitions for cutting-edge medical technologies, including in-vitro diagnostic systems, analytical laboratory instrumentation, and biosensor platforms designed for field-deployable health monitoring. Her work directly enables rapid pathogen identification, physiological stress assessment, and real-time health threat mitigation in operational environments, aligning procurement activities with the Center’s strategic R&D priorities. While specific contractor names are not publicly available, Huston’s procurement patterns indicate consistent engagement with specialized biomedical manufacturers and precision instrument suppliers, particularly those capable of delivering validated, FDA-regulated diagnostic solutions and ruggedized analytical equipment. She fosters partnerships with vendors possessing expertise in clinical validation, regulatory compliance, and rapid prototyping for military applications, often requiring adherence to military specifications and traceable quality assurance protocols. Huston demonstrates a strong commitment to small business participation, with approximately one-third of her acquisitions structured as total small business set-asides under FAR 19.5. Her contracting approach reflects a deliberate emphasis on enabling innovation from small and emerging firms, particularly those with capabilities in diagnostic manufacturing and laboratory instrumentation, while maintaining flexibility to source from larger entities when technical requirements demand scale or specialized certification. Her primary procurement focus lies in NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), reflecting deep technical expertise in diagnostic assays, point-of-care testing systems, and biosensor integration. She also occasionally procures specialized maintenance services (811210) and supports research collaborations through academic institutions (611310), ensuring a balanced ecosystem of innovation, production, and sustainment for next-generation military medical technologies.